Table of Content

1 Study Coverage
1.1 Gabapentin Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.3 Market by Application
1.3.1 Global Gabapentin Market Size Growth Rate by Application
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Gabapentin Sales Estimates and Forecasts 2016-2027
2.2 Global Gabapentin Revenue Estimates and Forecasts 2016-2027
2.3 Global Gabapentin Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Gabapentin Regions by Sales
2.4.1 Global Top Gabapentin Regions by Sales (2016-2021)
2.4.2 Global Top Gabapentin Regions by Sales (2022-2027)
2.5 Global Top Gabapentin Regions by Revenue
2.5.1 Global Top Gabapentin Regions by Revenue (2016-2021)
2.5.2 Global Top Gabapentin Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gabapentin Sales by Manufacturers
3.1.1 Global Top Gabapentin Manufacturers by Sales (2016-2021)
3.1.2 Global Top Gabapentin Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Gabapentin Sales in 2020
3.2 Global Gabapentin Revenue by Manufacturers
3.2.1 Global Top Gabapentin Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Gabapentin Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Revenue in 2020
3.3 Global Gabapentin Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gabapentin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Gabapentin Sales by Type
4.1.1 Global Gabapentin Historical Sales by Type (2016-2021)
4.1.2 Global Gabapentin Forecasted Sales by Type (2022-2027)
4.1.3 Global Gabapentin Sales Market Share by Type (2016-2027)
4.2 Global Gabapentin Revenue by Type
4.2.1 Global Gabapentin Historical Revenue by Type (2016-2021)
4.2.2 Global Gabapentin Forecasted Revenue by Type (2022-2027)
4.2.3 Global Gabapentin Revenue Market Share by Type (2016-2027)
4.3 Global Gabapentin Price by Type
4.3.1 Global Gabapentin Price by Type (2016-2021)
4.3.2 Global Gabapentin Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Gabapentin Sales by Application
5.1.1 Global Gabapentin Historical Sales by Application (2016-2021)
5.1.2 Global Gabapentin Forecasted Sales by Application (2022-2027)
5.1.3 Global Gabapentin Sales Market Share by Application (2016-2027)
5.2 Global Gabapentin Revenue by Application
5.2.1 Global Gabapentin Historical Revenue by Application (2016-2021)
5.2.2 Global Gabapentin Forecasted Revenue by Application (2022-2027)
5.2.3 Global Gabapentin Revenue Market Share by Application (2016-2027)
5.3 Global Gabapentin Price by Application
5.3.1 Global Gabapentin Price by Application (2016-2021)
5.3.2 Global Gabapentin Price Forecast by Application (2022-2027)

6 North America
6.1 North America Gabapentin Market Size by Type
6.1.1 North America Gabapentin Sales by Type (2016-2027)
6.1.2 North America Gabapentin Revenue by Type (2016-2027)
6.2 North America Gabapentin Market Size by Application
6.2.1 North America Gabapentin Sales by Application (2016-2027)
6.2.2 North America Gabapentin Revenue by Application (2016-2027)
6.3 North America Gabapentin Market Size by Country
6.3.1 North America Gabapentin Sales by Country (2016-2027)
6.3.2 North America Gabapentin Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Gabapentin Market Size by Type
7.1.1 Europe Gabapentin Sales by Type (2017-2027)
7.1.2 Europe Gabapentin Revenue by Type (2017-2027)
7.2 Europe Gabapentin Market Size by Application
7.2.1 Europe Gabapentin Sales by Application (2017-2027)
7.2.2 Europe Gabapentin Revenue by Application (2017-2027)
7.3 Europe Gabapentin Market Size by Country
7.3.1 Europe Gabapentin Sales by Country (2017-2027)
7.3.2 Europe Gabapentin Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gabapentin Market Size by Type
8.1.1 Asia Pacific Gabapentin Sales by Type (2018-2027)
8.1.2 Asia Pacific Gabapentin Revenue by Type (2018-2027)
8.2 Asia Pacific Gabapentin Market Size by Application
8.2.1 Asia Pacific Gabapentin Sales by Application (2018-2027)
8.2.2 Asia Pacific Gabapentin Revenue by Application (2018-2027)
8.3 Asia Pacific Gabapentin Market Size by Region
8.3.1 Asia Pacific Gabapentin Sales by Region (2018-2027)
8.3.2 Asia Pacific Gabapentin Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Gabapentin Market Size by Type
9.1.1 Latin America Gabapentin Sales by Type (2019-2027)
9.1.2 Latin America Gabapentin Revenue by Type (2019-2027)
9.2 Latin America Gabapentin Market Size by Application
9.2.1 Latin America Gabapentin Sales by Application (2019-2027)
9.2.2 Latin America Gabapentin Revenue by Application (2019-2027)
9.3 Latin America Gabapentin Market Size by Country
9.3.1 Latin America Gabapentin Sales by Country (2019-2027)
9.3.2 Latin America Gabapentin Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Gabapentin Market Size by Type
6.1.1 Middle East and Africa Gabapentin Sales by Type (2016-2027)
6.1.2 Middle East and Africa Gabapentin Revenue by Type (2016-2027)
6.2 Middle East and Africa Gabapentin Market Size by Application
6.2.1 Middle East and Africa Gabapentin Sales by Application (2016-2027)
6.2.2 Middle East and Africa Gabapentin Revenue by Application (2016-2027)
6.3 Middle East and Africa Gabapentin Market Size by Country
6.3.1 Middle East and Africa Gabapentin Sales by Country (2016-2027)
6.3.2 Middle East and Africa Gabapentin Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Pfizer Gabapentin Product Description
11.1.5 Pfizer Related Developments
11.2 Assertio Therapeutics
11.2.1 Assertio Therapeutics Corporation Information
11.2.2 Assertio Therapeutics Overview
11.2.3 Assertio Therapeutics Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Assertio Therapeutics Gabapentin Product Description
11.2.5 Assertio Therapeutics Related Developments
11.3 TEVA
11.3.1 TEVA Corporation Information
11.3.2 TEVA Overview
11.3.3 TEVA Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 TEVA Gabapentin Product Description
11.3.5 TEVA Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Mylan Gabapentin Product Description
11.4.5 Mylan Related Developments
11.5 Arbor Pharma
11.5.1 Arbor Pharma Corporation Information
11.5.2 Arbor Pharma Overview
11.5.3 Arbor Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Arbor Pharma Gabapentin Product Description
11.5.5 Arbor Pharma Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Novartis Gabapentin Product Description
11.6.5 Novartis Related Developments
11.7 Apotex
11.7.1 Apotex Corporation Information
11.7.2 Apotex Overview
11.7.3 Apotex Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Apotex Gabapentin Product Description
11.7.5 Apotex Related Developments
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Corporation Information
11.8.2 Sun Pharmaceutical Overview
11.8.3 Sun Pharmaceutical Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Sun Pharmaceutical Gabapentin Product Description
11.8.5 Sun Pharmaceutical Related Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Corporation Information
11.9.2 Aurobindo Pharma Overview
11.9.3 Aurobindo Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Aurobindo Pharma Gabapentin Product Description
11.9.5 Aurobindo Pharma Related Developments
11.10 Intas
11.10.1 Intas Corporation Information
11.10.2 Intas Overview
11.10.3 Intas Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Intas Gabapentin Product Description
11.10.5 Intas Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Pfizer Gabapentin Product Description
11.1.5 Pfizer Related Developments
11.12 Marksans Pharma
11.12.1 Marksans Pharma Corporation Information
11.12.2 Marksans Pharma Overview
11.12.3 Marksans Pharma Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Marksans Pharma Product Description
11.12.5 Marksans Pharma Related Developments
11.13 Glenmark
11.13.1 Glenmark Corporation Information
11.13.2 Glenmark Overview
11.13.3 Glenmark Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Glenmark Product Description
11.13.5 Glenmark Related Developments
11.14 Alkem
11.14.1 Alkem Corporation Information
11.14.2 Alkem Overview
11.14.3 Alkem Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Alkem Product Description
11.14.5 Alkem Related Developments
11.15 Jiangsu Enhua
11.15.1 Jiangsu Enhua Corporation Information
11.15.2 Jiangsu Enhua Overview
11.15.3 Jiangsu Enhua Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Jiangsu Enhua Product Description
11.15.5 Jiangsu Enhua Related Developments
11.16 Jiangsu Hengrui
11.16.1 Jiangsu Hengrui Corporation Information
11.16.2 Jiangsu Hengrui Overview
11.16.3 Jiangsu Hengrui Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Jiangsu Hengrui Product Description
11.16.5 Jiangsu Hengrui Related Developments
11.17 Sailike
11.17.1 Sailike Corporation Information
11.17.2 Sailike Overview
11.17.3 Sailike Gabapentin Sales, Price, Revenue and Gross Margin (2016-2021)
11.17.4 Sailike Product Description
11.17.5 Sailike Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Gabapentin Value Chain Analysis
12.2 Gabapentin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gabapentin Production Mode & Process
12.4 Gabapentin Sales and Marketing
12.4.1 Gabapentin Sales Channels
12.4.2 Gabapentin Distributors
12.5 Gabapentin Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gabapentin Industry Trends
13.2 Gabapentin Market Drivers
13.3 Gabapentin Market Challenges
13.4 Gabapentin Market Restraints

14 Key Findings in The Global Gabapentin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Gabapentin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Gabapentin Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Gabapentin Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Gabapentin Sales by Region (2016-2021) & (K MT)
Table 7. Global Gabapentin Sales Market Share by Region (2016-2021)
Table 8. Global Gabapentin Sales by Region (2016-2021) & (K MT)
Table 9. Global Gabapentin Sales Market Share by Region (2022-2027)
Table 10. Global Gabapentin Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Gabapentin Revenue Market Share by Region (2016-2021)
Table 12. Global Gabapentin Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Gabapentin Revenue Market Share by Region (2022-2027)
Table 14. Global Gabapentin Sales by Manufacturers (2016-2021) & (K MT)
Table 15. Global Gabapentin Sales Share by Manufacturers (2016-2021)
Table 16. Global Gabapentin Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Gabapentin Revenue Share by Manufacturers (2016-2021)
Table 18. Gabapentin Price by Manufacturers 2016-2021 (USD/MT)
Table 19. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Gabapentin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2020)
Table 21. Gabapentin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gabapentin Product Offered
Table 23. Date of Manufacturers Enter into Gabapentin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gabapentin Sales by Type (2016-2021) & (K MT)
Table 26. Global Gabapentin Sales by Type (2022-2027) & (K MT)
Table 27. Global Gabapentin Sales Share by Type (2016-2021)
Table 28. Global Gabapentin Sales Share by Type (2022-2027)
Table 29. Global Gabapentin Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Gabapentin Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Gabapentin Revenue Share by Type (2016-2021)
Table 32. Global Gabapentin Revenue Share by Type (2022-2027)
Table 33. Gabapentin Price by Type (2016-2021) & (USD/MT)
Table 34. Global Gabapentin Price Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Gabapentin Sales by Application (2016-2021) & (K MT)
Table 36. Global Gabapentin Sales by Application (2022-2027) & (K MT)
Table 37. Global Gabapentin Sales Share by Application (2016-2021)
Table 38. Global Gabapentin Sales Share by Application (2022-2027)
Table 39. Global Gabapentin Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Gabapentin Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Gabapentin Revenue Share by Application (2016-2021)
Table 42. Global Gabapentin Revenue Share by Application (2022-2027)
Table 43. Gabapentin Price by Application (2016-2021) & (USD/MT)
Table 44. Global Gabapentin Price Forecast by Application (2022-2027) & (USD/MT)
Table 45. North America Gabapentin Sales by Type (2016-2021) & (K MT)
Table 46. North America Gabapentin Sales by Type (2022-2027) & (K MT)
Table 47. North America Gabapentin Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Gabapentin Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Gabapentin Sales by Application (2016-2021) & (K MT)
Table 50. North America Gabapentin Sales by Application (2022-2027) & (K MT)
Table 51. North America Gabapentin Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Gabapentin Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Gabapentin Sales by Country (2016-2021) & (K MT)
Table 54. North America Gabapentin Sales by Country (2022-2027) & (K MT)
Table 55. North America Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Gabapentin Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Gabapentin Sales by Type (2016-2021) & (K MT)
Table 58. Europe Gabapentin Sales by Type (2022-2027) & (K MT)
Table 59. Europe Gabapentin Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Gabapentin Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Gabapentin Sales by Application (2016-2021) & (K MT)
Table 62. Europe Gabapentin Sales by Application (2022-2027) & (K MT)
Table 63. Europe Gabapentin Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Gabapentin Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Gabapentin Sales by Country (2016-2021) & (K MT)
Table 66. Europe Gabapentin Sales by Country (2022-2027) & (K MT)
Table 67. Europe Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Gabapentin Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Gabapentin Sales by Type (2016-2021) & (K MT)
Table 70. Asia Pacific Gabapentin Sales by Type (2022-2027) & (K MT)
Table 71. Asia Pacific Gabapentin Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Gabapentin Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Gabapentin Sales by Application (2016-2021) & (K MT)
Table 74. Asia Pacific Gabapentin Sales by Application (2022-2027) & (K MT)
Table 75. Asia Pacific Gabapentin Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Gabapentin Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Gabapentin Sales by Region (2016-2021) & (K MT)
Table 78. Asia Pacific Gabapentin Sales by Region (2022-2027) & (K MT)
Table 79. Asia Pacific Gabapentin Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Gabapentin Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Gabapentin Sales by Type (2016-2021) & (K MT)
Table 82. Latin America Gabapentin Sales by Type (2022-2027) & (K MT)
Table 83. Latin America Gabapentin Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Gabapentin Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Gabapentin Sales by Application (2016-2021) & (K MT)
Table 86. Latin America Gabapentin Sales by Application (2022-2027) & (K MT)
Table 87. Latin America Gabapentin Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Gabapentin Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Gabapentin Sales by Country (2016-2021) & (K MT)
Table 90. Latin America Gabapentin Sales by Country (2022-2027) & (K MT)
Table 91. Latin America Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Gabapentin Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Gabapentin Sales by Type (2016-2021) & (K MT)
Table 94. Middle East and Africa Gabapentin Sales by Type (2022-2027) & (K MT)
Table 95. Middle East and Africa Gabapentin Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Gabapentin Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Gabapentin Sales by Application (2016-2021) & (K MT)
Table 98. Middle East and Africa Gabapentin Sales by Application (2022-2027) & (K MT)
Table 99. Middle East and Africa Gabapentin Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Gabapentin Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Gabapentin Sales by Country (2016-2021) & (K MT)
Table 102. Middle East and Africa Gabapentin Sales by Country (2022-2027) & (K MT)
Table 103. Middle East and Africa Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Gabapentin Revenue by Country (2022-2027) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 108. Pfizer Gabapentin Product
Table 109. Pfizer Recent Developments
Table 110. Assertio Therapeutics Corporation Information
Table 111. Assertio Therapeutics Description and Major Businesses
Table 112. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Assertio Therapeutics Gabapentin Product
Table 114. Assertio Therapeutics Recent Developments
Table 115. TEVA Corporation Information
Table 116. TEVA Description and Major Businesses
Table 117. TEVA Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. TEVA Gabapentin Product
Table 119. TEVA Recent Developments
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Major Businesses
Table 122. Mylan Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Mylan Gabapentin Product
Table 124. Mylan Recent Developments
Table 125. Arbor Pharma Corporation Information
Table 126. Arbor Pharma Description and Major Businesses
Table 127. Arbor Pharma Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Arbor Pharma Gabapentin Product
Table 129. Arbor Pharma Recent Developments
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Major Businesses
Table 132. Novartis Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Novartis Gabapentin Product
Table 134. Novartis Recent Developments
Table 135. Apotex Corporation Information
Table 136. Apotex Description and Major Businesses
Table 137. Apotex Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Apotex Gabapentin Product
Table 139. Apotex Recent Developments
Table 140. Sun Pharmaceutical Corporation Information
Table 141. Sun Pharmaceutical Description and Major Businesses
Table 142. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Sun Pharmaceutical Gabapentin Product
Table 144. Sun Pharmaceutical Recent Developments
Table 145. Aurobindo Pharma Corporation Information
Table 146. Aurobindo Pharma Description and Major Businesses
Table 147. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 148. Aurobindo Pharma Gabapentin Product
Table 149. Aurobindo Pharma Recent Developments
Table 150. Intas Corporation Information
Table 151. Intas Description and Major Businesses
Table 152. Intas Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 153. Intas Gabapentin Product
Table 154. Intas Recent Developments
Table 155. Amneal Corporation Information
Table 156. Amneal Description and Major Businesses
Table 157. Amneal Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Amneal Gabapentin Product
Table 159. Amneal Recent Developments
Table 160. Marksans Pharma Corporation Information
Table 161. Marksans Pharma Description and Major Businesses
Table 162. Marksans Pharma Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Marksans Pharma Gabapentin Product
Table 164. Marksans Pharma Recent Developments
Table 165. Glenmark Corporation Information
Table 166. Glenmark Description and Major Businesses
Table 167. Glenmark Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Glenmark Gabapentin Product
Table 169. Glenmark Recent Developments
Table 170. Alkem Corporation Information
Table 171. Alkem Description and Major Businesses
Table 172. Alkem Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Alkem Gabapentin Product
Table 174. Alkem Recent Developments
Table 175. Jiangsu Enhua Corporation Information
Table 176. Jiangsu Enhua Description and Major Businesses
Table 177. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Jiangsu Enhua Gabapentin Product
Table 179. Jiangsu Enhua Recent Developments
Table 180. Jiangsu Hengrui Corporation Information
Table 181. Jiangsu Hengrui Description and Major Businesses
Table 182. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Jiangsu Hengrui Gabapentin Product
Table 184. Jiangsu Hengrui Recent Developments
Table 185. Sailike Corporation Information
Table 186. Sailike Description and Major Businesses
Table 187. Sailike Gabapentin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Sailike Gabapentin Product
Table 189. Sailike Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Gabapentin Distributors List
Table 193. Gabapentin Customers List
Table 194. Gabapentin Market Trends
Table 195. Gabapentin Market Drivers
Table 196. Gabapentin Market Challenges
Table 197. Gabapentin Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Product Picture
Figure 2. Global Gabapentin Market Share by Type in 2020 & 2027
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Gabapentin Sales Market Share by Application in 2020 & 2027
Figure 6. Epilepsy
Figure 7. Neuropathic Pain
Figure 8. Restless Legs Syndrome
Figure 9. Others
Figure 10. Gabapentin Report Years Considered
Figure 11. Global Gabapentin Sales 2016-2027 (K MT)
Figure 12. Global Gabapentin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gabapentin Revenue 2016-2027 (US$ Million)
Figure 14. Global Gabapentin Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Gabapentin Sales Market Share by Region (2016-2021)
Figure 16. Global Gabapentin Sales Market Share by Region (2022-2027)
Figure 17. North America Gabapentin Sales YoY (2016-2027) & (K MT)
Figure 18. North America Gabapentin Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Gabapentin Sales YoY (2016-2027) & (K MT)
Figure 20. Europe Gabapentin Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Gabapentin Sales YoY (2016-2027) & (K MT)
Figure 22. Asia-Pacific Gabapentin Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Gabapentin Sales YoY (2016-2027) & (K MT)
Figure 24. Latin America Gabapentin Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Gabapentin Sales YoY (2016-2027) & (K MT)
Figure 26. Middle East & Africa Gabapentin Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Gabapentin Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Gabapentin Revenue in 2020
Figure 29. Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Gabapentin Sales Market Share by Type (2016-2027)
Figure 31. Global Gabapentin Revenue Market Share by Type (2016-2027)
Figure 32. Global Gabapentin Sales Market Share by Application (2016-2027)
Figure 33. Global Gabapentin Revenue Market Share by Application (2016-2027)
Figure 34. North America Gabapentin Sales Market Share by Type (2016-2027)
Figure 35. North America Gabapentin Revenue Market Share by Type (2016-2027)
Figure 36. North America Gabapentin Sales Market Share by Application (2016-2027)
Figure 37. North America Gabapentin Revenue Market Share by Application (2016-2027)
Figure 38. North America Gabapentin Sales Share by Country (2016-2027)
Figure 39. North America Gabapentin Revenue Share by Country (2016-2027)
Figure 40. U.S. Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Gabapentin Sales Market Share by Type (2016-2027)
Figure 43. Europe Gabapentin Revenue Market Share by Type (2016-2027)
Figure 44. Europe Gabapentin Sales Market Share by Application (2016-2027)
Figure 45. Europe Gabapentin Revenue Market Share by Application (2016-2027)
Figure 46. Europe Gabapentin Sales Share by Country (2016-2027)
Figure 47. Europe Gabapentin Revenue Share by Country (2016-2027)
Figure 48. Germany Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 49. France Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Gabapentin Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Gabapentin Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Gabapentin Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Gabapentin Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Gabapentin Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Gabapentin Revenue Share by Region (2016-2027)
Figure 59. China Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 62. India Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 68. Philippines Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Gabapentin Sales Market Share by Type (2016-2027)
Figure 70. Latin America Gabapentin Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Gabapentin Sales Market Share by Application (2016-2027)
Figure 72. Latin America Gabapentin Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Gabapentin Sales Share by Country (2016-2027)
Figure 74. Latin America Gabapentin Revenue Share by Country (2016-2027)
Figure 75. Mexico Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Gabapentin Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Gabapentin Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Gabapentin Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Gabapentin Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Gabapentin Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Gabapentin Revenue Share by Country (2016-2027)
Figure 84. Turkey Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 86. U.A.E Gabapentin Revenue (2016-2027) & (US$ Million)
Figure 87. Gabapentin Value Chain
Figure 88. Gabapentin Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed